Tci Wealth Advisors, Inc. Surface Oncology, Inc. Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$0.62 - $1.21 $62 - $121	-100 Reduced 31.25%	220 $0
Q4 2021 Jan 24, 2022	BUY	$4.73 - $7.9 $473 - $790	100 Added 45.45%	320 $2,000
Q3 2021 Oct 29, 2021	BUY	$5.16 - $7.98 $516 - $798	100 Added 83.33%	220 $2,000
Q2 2021 Aug 02, 2021	BUY	$6.45 - $9.09 $645 - $909	100 Added 500.0%	120 $1,000
Q1 2021 Apr 29, 2021	BUY	$7.25 - $13.82 $145 - $276	20 New	20 $0

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.